MisaghKarimiMDAssistant Clinical Professor

PubMed

• 5 citations
  Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
  Colt A Egelston, Weihua Guo, Susan E Yost, Xuan Ge, Jin Sun Lee, Paul H Frankel, Yujie Cui, Christopher Ruel, Daniel Schmolze, Mireya Murga, Aileen Tang, Norma Martine...> ;Cancer Immunology, Immunotherapy. 2023 Sep 1
• Proposed Implementation of a Patient-Centered Self-Assessment Tool for Patients with Neuroendocrine Tumors among Academic and Community Practice Sites: The City of Hop...
  Christiana Joy Crook, Lisa Yen, Kathleen Ta, Misagh Karimi, Danny Nguyen, Richard T Lee, Daneng Li> ;Journal of Clinical Medicine. 2023 Feb 3
• 4 citations
  Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group
  Arturo Loaiza-Bonilla, Al B. Benson, Axel Grothey, Misagh Karimi, Samuel J. Klempner, Daniel Lin, Reshma Mahtani, Heloisa P. Soares> ;The Oncologist. 2021 Aug 1
• 5 citations
  Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model.
  Misagh Karimi, Chongkai Wang, Bahareh Bahadini, George Hajjar> ;Journal of Clinical Medicine. 2020 Jun 2
• 9 citations
  Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer
  Linda D. Bosserman, Karl Rogers, Carl Rogaston Willis, Dirk C. Davidson, Pat Whitworth, Misagh Karimi, G. Upadhyaya, James Rutledge, Allan Hallquist, Mathieu Perree, C...> ;Plos One. 2015 May 29
• 14 citations
  The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care
  Linda D. Bosserman, Franklyn G Prendergast, Roy S. Herbst, Martin Fleisher, Emery M. Salom, Steven Strickland, Anastasios Raptis, Allan Hallquist, Mathieu Perree, Swap...> ;Cancer Research. 2012 Aug 15
• Join now to see all